SourceBio International PLC - laboratory services provider - Says it has entered into a strategic commercial partnership with DNA/RNA sequencing technology company Oxford Nanopore Technologies Ltd, to offer a commercially available Covid-19 testing solution to corporate customers at scale. The test will also be offered to consumers.
Chair Jay LeCoque said: "The UK government has minimum standards for private sector providers of COVID-19 testing and we are delighted to have been awarded full UKAS ISO15189 status for our Covid testing. Very few commercial institutions have received this standard and it is a mandatory requirement from next summer 2021. This underscores the high standard of our accredited testing services and provides us with a significant advantage in the market."
Current stock price: 170 pence
Year-to-date change: up 4.7% from October's IPO price of 162p
By Arvind Bhunjun; arvindbhunjun@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
